olivLaw · European equity research
Pjp Makrum S.A. PJP.WA
Poland · GPW Warszawa · ISIN PLPROJP00018 · Vertical: Listed companies from Poland
At the close of 06 Nov 2026, Pjp Makrum S.A. (PJP.WA) stock was 20.20 PLN (−5.61% on the day), with market capitalisation 122.4 m PLN, P/E 65.2 on diluted EPS of 0.31 PLN over the last 12 months, dividend yield 1.66%, beta 0.31, 52-week range 13.55–25.00 PLN.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 31.1
- weak (30–45)
- Bollinger (20, 2)
- 20.73 – 22.83
- below the lower band · %B -0.25 · band width 9.7%
- SMA 50 / 200
- 21.95 / 19.51
- mixed trend
- MACD (12, 26, 9)
- -0.25 / -0.10
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | −10.2% | −0.6% | −9.6 pp | — |
| 3 months | −3.8% | −4.2% | +0.4 pp | — |
| 6 months | +13.8% | +4.3% | +9.5 pp | — |
| Year to date | +38.4% | +7.5% | +30.8 pp | — |
| 1 year | +31.2% | +9.9% | +21.2 pp | +5.9% |
| 3 years | +28.7% | +49.8% | −21.2 pp | +1.8% |
| 5 years | +45.3% | +42.8% | +2.5 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 100 percentile of its own 2-quarter history (min 6.5, median 23.2, max 40.0; quarters with earnings only).
Fiscal years
| Fiscal year | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenue | 341.9 m | 312.1 m | 532.4 m |
| Revenue YoY | unavailable | −8.7% | +70.6% |
| Net income | 14.9 m | 1.9 m | 28.6 m |
| Net income YoY | unavailable | −87.4% | +1,420.2% |
| Diluted EPS | 2.49 | 0.31 | unavailable |
| Diluted EPS YoY | unavailable | −87.6% | unavailable |
| net % | 4.3% | 0.6% | 5.4% |
| Free cash flow | 14.4 m | 10.1 m | 20.9 m |
Balance sheet & financial health
Fiscal year 2022 · 31 Dec 2022
- Cash
- 29.4 m PLN
- Financial debt
- 2.0 m PLN
- Net debt
- -27.4 m PLN
- Equity
- 148.5 m PLN
- Total assets
- 344.7 m PLN
- Debt / equity
- 0.01x
- Current ratio
- 1.37x
- ROE
- 21.3%
- ROA
- 8.7%
- FCF margin
- 3.9%
Financial statements (source on every figure)
Revenue and net income (PLN)
Margins
Income statement · PLN
| Line | 2020 | 2021 | 2022 | Source (latest year) |
|---|---|---|---|---|
| Revenue | 341.9 m | 312.1 m | 532.4 m | esef· 09 May 2023verified |
| Cost of revenue | 271.6 m | 256.2 m | 429.3 m | esef· 09 May 2023verified |
| Gross profit | 70.3 m | 55.9 m | 103.1 m | esef· 09 May 2023verified |
| Operating income | 21.9 m | 2.3 m | 35.2 m | esef· 09 May 2023verified |
| Interest expense | 3.9 m | 3.0 m | 6.7 m | esef· 09 May 2023verified |
| Pre-tax income | 20.2 m | 3.5 m | 35.6 m | esef· 09 May 2023verified |
| Income tax | 5.4 m | 1.7 m | 7.0 m | esef· 09 May 2023verified |
| Net income | 14.9 m | 1.9 m | 28.6 m | esef· 09 May 2023verified |
| Diluted EPS | 2.49 | 0.31 | — | esef· 05 Apr 2022verified |
| Dividend per share | 0.60 | 0.34 | — | esef· 05 Apr 2022derived |
Balance sheet · PLN
| Line | 2020 | 2021 | 2022 | Source (latest year) |
|---|---|---|---|---|
| Cash | 9.8 m | 17.7 m | 29.4 m | esef· 09 May 2023verified |
| Inventories | 32.2 m | 63.1 m | 80.8 m | esef· 09 May 2023verified |
| Current assets | 127.4 m | 176.0 m | 232.3 m | esef· 09 May 2023verified |
| Property, plant & equipment, net | 30.1 m | 35.8 m | 34.0 m | esef· 09 May 2023verified |
| Goodwill | 31.1 m | 31.1 m | 31.1 m | esef· 09 May 2023verified |
| Intangibles (excl. goodwill) | 3.9 m | 3.6 m | 3.1 m | esef· 09 May 2023verified |
| Total assets | 243.9 m | 314.5 m | 344.7 m | esef· 09 May 2023verified |
| Accounts payable | 53.0 m | 89.7 m | 86.4 m | esef· 09 May 2023verified |
| Long-term debt | 7.2 m | 6.7 m | 2.0 m | esef· 09 May 2023verified |
| Current liabilities | 99.8 m | 167.5 m | 169.1 m | esef· 09 May 2023verified |
| Total liabilities | 124.1 m | 195.0 m | 196.2 m | esef· 09 May 2023verified |
| Equity | 119.8 m | 119.5 m | 148.5 m | esef· 09 May 2023verified |
| Shares outstanding at year end | 6.0 m | 6.1 m | — | esef· 09 May 2023derived |
Cash flow · PLN
| Line | 2020 | 2021 | 2022 | Source (latest year) |
|---|---|---|---|---|
| Operating cash flow | 27.0 m | 18.2 m | 22.5 m | esef· 09 May 2023verified |
| Capex | 12.6 m | 8.1 m | 1.5 m | esef· 09 May 2023verified |
| Free cash flow | 14.4 m ≈ | 10.1 m ≈ | 20.9 m ≈ | esef· 09 May 2023derived |
| Investing cash flow | -26.4 m | -12.9 m | 4.8 m | esef· 09 May 2023verified |
| Financing cash flow | -3.3 m | 2.6 m | -15.6 m | esef· 09 May 2023verified |
| Dividends paid | 3.6 m | 2.0 m | 0 | esef· 09 May 2023verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 68 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
06 Nov 2026Source: olivLaw, closing series
Market cap: 122.4 m PLN
Key indicators
Coverage and freshness
The data is older than the freshness threshold.
Score by group
- Quality69
- Balance sheet53
- Valuation91
- Returns40
Estimated value range
unavailable — no valuation assumptions for the reporting currency
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
Assumptions (illustrative, editorial)
- Risk-free rate
- 6.5%
- Equity risk premium
- 6.0%
- Beta (default)
- 1.00
- Cost of equity
- 12.5%
- Terminal growth
- 3.0%
Factor scorecard
Neutral profile · Score 68/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 24.6% | 80 (vs peers) | 17% |
| Net margin · Quality | 5.4% | 56 (vs peers) | 10% |
| FCF conversion · Quality | 73.3% | 62 (on a fixed band) | 10% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 5.2x | 57 (on a fixed band) | 10% |
| Current ratio · Balance sheet | 1.4x | 48 (on a fixed band) | 7% |
| P/E (TTM) · Valuation | 4.3x | 84 (vs peers) | 17% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 17.1% | 100 (on a fixed band) | 13% |
| Shareholder yield (distributions) · Returns | 0.0% | 0 (on a fixed band) | 10% |
| Payout ratio (FCF) · Returns | 0.0% | 100 (on a fixed band) | 7% |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet53/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality69/100 · 3/3 factors with a value
- Returns40/100 · 2/2 factors with a value
- Valuation91/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
PJP MAKRUM S.A. (PJP.WA). Latest full fiscal year: 2022; data up to 2022-12-31.
Figures computed from the financial statements: revenue 532.4 m PLN in 2022; YoY growth 70.6%; net margin 5.4%; ROE 21.3%.
The estimated value range is 27.84–76.92 PLN per share (median of 3 methods, agreement: low); assumptions are illustrative. Against the central value of 48.17 PLN, the price of 20.20 PLN leaves a potential of 138.5% (value / price − 1) and a margin of safety of 58.1% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 68/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: growth. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- ROIC: 24.6%
- P/E (TTM): 4.3x
- FCF yield: 17.1%
- Payout ratio (FCF): 0.0%
- The price is below the estimated value range
What contradicts it
- Shareholder yield (distributions): 0.0%
- The valuation methods diverge
Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA.
Versus the vertical median
Listed companies from Poland · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ACP.WAAsseco Poland S.A. | 19.0 bn | 37.8 | 7.8% | 2.9% | +19.8% | +18% / +199% |
| BDX.WABudimex Spółka Akcyjna | 18.9 bn | 35.3 | 41.5% | 6.2% | +8.9% | +18% / +33% |
| BFT.WABenefit Systems Spółka Akcyjna | 18.1 bn | 130.7 | 20.8% | 7.2% | +99.9% | +74% / +221% |
| ASE.WAAsseco South Eastern Europe Spółka Akcyjna | 3.7 bn | 19.6 | 18.1% | 12.0% | +36.5% | +6% / +50% |
| 1AT.WAAtal Spółka Akcyjna | 2.3 bn | 6.4 | 29.8% | 22.2% | −1.3% | +7% / +8% |
| ATT.WAGrupa Azoty Spółka Akcyjna | 1.6 bn | — | -37.9% | -20.8% | −45.1% | −15% / −26% |
| ARH.WAArchicom Spółka Akcyjna | 1.3 bn | 12.1 | 15.9% | 22.1% | −21.6% | +13% / +88% |
| ACT.WAAction S.A. | 999.4 m | 27.2 | 8.3% | 1.5% | +6.1% | +71% / +171% |
| BRS.WABoryszew Spółka Akcyjna | 874.1 m | 8.2 | 6.3% | 1.6% | +8.4% | −25% / −28% |
| AGO.WAAgora Spółka Akcyjna | 588.0 m | — | -14.2% | -9.2% | +15.2% | +37% / +18% |
| AMB.WAAmbra S.A. | 462.9 m | 7.5 | 16.4% | 7.0% | +12.9% | +4% / −33% |
| ATC.WAArctic Paper Spółka Akcyjna | 344.7 m | 1.4 | 16.3% | 7.0% | −27.5% | −40% / −75% |
| ATG.WA"atm Grupa Spółka Akcyjna" | 298.5 m | 11.0 | 8.9% | 11.6% | −22.0% | −11% / +2% |
| ART.WAArtifex Mundi S.A. | 229.7 m | 17.7 | 35.7% | 33.3% | +51.9% | +48% / +14% |
| APN.WAAPLISENS Spółka Akcyjna | 192.4 m | 9.4 | 11.4% | 13.8% | +21.8% | −2% / −22% |
| ALI.WAALTUS Spolka Akcyjna | 158.1 m | 17.3 | 7.9% | 16.9% | +30.3% | +38% / +52% |
| BMC.WABumech Spółka Akcyjna | 156.9 m | — | -3.4% | -3.9% | −40.0% | −36% / −49% |
| PJP.WAPjp Makrum S.A. | 122.4 m | 4.3 | 21.3% | 5.4% | +70.6% | +36% / +35% |
| BBT.WABoomBit Spółka Akcyjna | 71.9 m | 4.5 | 20.7% | 6.4% | −16.5% | −18% / −56% |
| BBD.WABbi Development S.A. | 54.1 m | 1.1 | 36.0% | 208.3% | +50.2% | +1% / +9% |
| ALG.WAAll in! Games Spółka Akcyjna | 39.6 m | — | — | -156.9% | −72.2% | −27% / −56% |
| BMX.WABioMaxima Spółka Akcyjna | 36.3 m | 62.0 | 1.2% | 1.3% | −67.5% | −31% / −46% |
| 06N.WAMagna Polonia Spółka Akcyjna | 31.1 m | 0.5 | 115.4% | 964.7% | +13.0% | −29% / −43% |
| BCM.WABETACOM Spółka Akcyjna | 26.3 m | 17.3 | 8.0% | 0.9% | +21.3% | +6% / +2% |
| AWM.WAAirway Medix Spółka Akcyjna | 13.8 m | — | -25.8% | -117,400.0% | −97.7% | −26% / −45% |
1- and 3-year price returns: for PJP.WA from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (PLN)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 13.20 Total return -14% · Per year -14% | 23.23 Total return 42% · Per year 42% | 34.85 Total return 105% · Per year 105% |
| 3 years | 15.66 Total return 44% · Per year 13% | 30.72 Total return 145% · Per year 35% | 50.18 Total return 266% · Per year 54% |
| 5 years | 18.57 Total return 113% · Per year 16% | 40.63 Total return 282% · Per year 31% | 72.25 Total return 497% · Per year 43% |
- Exit P/E± 7.68
- Net margin± 5.38
- Annual revenue growth± 4.01
- Annual dilution± 0.45
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202209 May 2023
- Annual report 202105 Apr 2022
- Annual report 202105 Apr 2022
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.